Dermapharm opens the week with dividend focus, shares in SDAX trade
27.06.2026 - 12:55:12 | ad-hoc-news.deBy Christina Vogel, Background & Management desk. Reviewed prior to publication on 2026-06-27, 10:54.
Dermapharm (DE000A2GS5D8) starts Saturday with a dividend-led calendar focus. Finanzen100 lists the SDAX member in Frankfurt, and the AGM distribution of 0.88 euros per share is already visible in market coverage.
Dividend and listing
The latest visible company event is the annual general meeting resolution on a dividend of 0.88 euros per share. Finanzen100 also shows Dermapharm Holding in the SDAX and quotes the Frankfurt listing under the symbol DMP.
That puts the stock into a familiar German market frame. The venue anchor is Frankfurt, and the index anchor is the SDAX, both visible to domestic retail readers.
What the calendar shows
For Saturday reading, the dividend decision is the cleanest dated marker in the live sources. It gives the stock a concrete point in the calendar while the SDAX context keeps the name within the German small-cap universe.
The same source also shows a Frankfurt trading reference and a day low of 46.55 euros. That makes the current listing easy to place, even without stretching beyond what is live-verifiable.
All news and analysis on Dermapharm shares
Use this hub for background on Dermapharm Holding, its SDAX role, and future company updates.
What Dermapharm sells
Dermapharm develops and markets branded pharmaceuticals, OTC products, and specialty generics. Its business model also includes manufacturing for selected partners, which gives the group a broader base than a pure one-brand drug company.
Dermapharm shares at a glance
The Dermapharm shares (DE000A2GS5D8) traded in Frankfurt at 46.55 euros as of 2026-06-26, 16:30. That is the latest dated price reference visible in the live source used here.
Key data on Dermapharm shares
- Company: Dermapharm Holding SE
- ISIN: DE000A2GS5D8
- Ticker: DMP
- Trading venue: Frankfurt
- Price (as of 2026-06-26, 16:30): 46.55 euros
- Sector / industry: Pharmaceuticals
- Index membership: SDAX
Disclaimer: This article is for informational purposes only and does not constitute investment advice.
